Related Experiment Video
Updated: Apr 4, 2026
08:04
Author Spotlight: Investigating Islet Abnormalities and Function with a Pseudoislet Protocol
Published on: November 3, 2023
2.6K
Microfluidic platform for assessing pancreatic islet functionality through dielectric spectroscopy
K Heileman1, J Daoud1, C Hasilo2
1Biomedical Engineering Department, McGill University , Montreal, Quebec H3A 2B4, Canada.
Biomicrofluidics
|September 5, 2015
Summary
Researchers developed a novel microfluidic platform to monitor human pancreatic islet function in real-time. This technology aids in understanding diabetes and evaluating islet transplantation preparations.
Area of Science:
- Biomedical Engineering
- Endocrinology
- Cell Biology
Background:
- Human pancreatic islet function is crucial for glucose homeostasis but dynamic responses are rarely assessed.
- Understanding islet dysfunction is key to managing diabetes mellitus and improving transplantation outcomes.
Purpose of the Study:
- To develop an advanced microfluidic platform for in vitro culture and multi-parametric assessment of human islet responses.
- To enable real-time monitoring of islet functionality under various chemical and biochemical stimuli.
Main Methods:
- Fabrication and implementation of a microfluidic device with integrated interdigitated electrodes for impedance spectroscopy.
- Perifusion of human pancreatic islets within the microfluidic platform.
- Real-time impedance measurements to analyze dielectric parameters like cell membrane capacitance and cytoplasmic conductivity.
Main Results:
- Successful proof-of-concept validation by monitoring pancreatic islet impedance changes in response to varying glucose concentrations.
- Demonstrated the platform's capability to provide insights into islet proliferation, differentiation, viability, and functionality.
Conclusions:
- The developed microfluidic platform offers a novel technique to elucidate mechanisms of islet function and dysfunction.
- This technology can significantly improve the evaluation of islet preparations for transplantation and aid in diabetes therapeutics development.
